Kardigan, Inc. (KARD) Ownership
KARD ownership summary
as of October 18, 2026- Institutions
- 78.3% of shares outstanding
- Insiders
- 15.58% of shares outstanding
- Shares outstanding
- 93.5M
- Float
- 51.8M shares available to trade
- Short interest
- 5.57% 4.4M shares short
- Days to cover
- 5.62 short interest up 73.0% vs prior month
- Institutions 78.32%
- Insiders 15.58%
- Other investors 6.10%
KARD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | SCHF (GPE), LLC | 18.09% | 16.9M | $220.4M | +16.9M (0.0%) | June 30, 2026 |
| 2 | FMR Inc | 9.53% | 8.9M | $116.1M | +8.9M (0.0%) | June 30, 2026 |
| 3 | Perceptive Advisors LLC | 8.77% | 8.2M | $106.9M | +8.2M (0.0%) | June 30, 2026 |
| 4 | T. Rowe Price Investment Management,Inc. | 4.50% | 4.2M | $54.8M | +4.2M (0.0%) | June 30, 2026 |
| 5 | Capital Research Global Investors | 3.85% | 3.6M | $46.9M | +3.6M (0.0%) | June 30, 2026 |
| 6 | JPMorgan Chase & Co | 1.92% | 1.8M | $23.3M | +1.8M (0.0%) | June 30, 2026 |
| 7 | AllianceBernstein L.P. | 1.64% | 1.5M | $20.0M | +1.5M (0.0%) | June 30, 2026 |
| 8 | Liberty Mutual Group Asset Management Inc. | 1.28% | 1.2M | $15.6M | +1.2M (0.0%) | June 30, 2026 |
| 9 | Jennison Associates LLC | 0.97% | 904K | $11.8M | +903,575 (0.0%) | June 30, 2026 |
| 10 | Paradigm Biocapital Advisors LP | 0.96% | 900K | $11.7M | +900,000 (0.0%) | June 30, 2026 |
| 11 | Jupiter Topco LLC | 0.80% | 750K | $9.8M | +749,703 (0.0%) | June 30, 2026 |
| 12 | T. Rowe Price Associates, Inc. | 0.70% | 659K | $8.6M | +658,787 (0.0%) | June 30, 2026 |
| 13 | Massachusetts Financial Services Company | 0.70% | 650K | $8.5M | +650,000 (0.0%) | June 30, 2026 |
| 14 | The Goldman Sachs Group Inc | 0.69% | 645K | $8.4M | +644,969 (0.0%) | June 30, 2026 |
| 15 | Deep Track Capital, LP | 0.64% | 600K | $7.8M | +600,000 (0.0%) | June 30, 2026 |
| 16 | Woodline Partners LP | 0.44% | 414K | $5.4M | +413,980 (0.0%) | June 30, 2026 |
| 17 | Franklin Templeton Inc | 0.43% | 400K | $5.2M | +400,021 (0.0%) | June 30, 2026 |
| 18 | Suvretta Capital Management, LLC | 0.43% | 400K | $5.2M | +400,000 (0.0%) | June 30, 2026 |
| 19 | Bank of New York Mellon Corp | 0.40% | 378K | $4.9M | +377,758 (0.0%) | June 30, 2026 |
| 20 | Catalio Capital Management, LP | 0.33% | 312K | $4.1M | +312,500 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 20 holders added 53.4M shares and 0 cut 0.
KARD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | American Funds SMALLCAP World A | 3.75% | 3.5M | $45.7M | +3.5M (0.0%) | June 30, 2026 |
| 2 | T. Rowe Price Small-Cap Stock | 1.44% | 1.3M | $17.6M | +613,268 (+83.3%) | August 31, 2026 |
| 3 | Fidelity Contrafund | 1.34% | 1.3M | $16.3M | +22,742 (+1.9%) | August 31, 2026 |
| 4 | JPMorgan Small Cap Growth A | 0.87% | 811K | $10.6M | −12,684 (−1.5%) | August 31, 2026 |
| 5 | iShares Russell 2000 ETF | 0.79% | 736K | $9.6M | +19,503 (+2.7%) | September 30, 2026 |
| 6 | AB Small Cap Growth A | 0.66% | 617K | $8.0M | −120,630 (−16.4%) | August 31, 2026 |
| 7 | T. Rowe Price Small-Cap Value | 0.66% | 615K | $8.0M | −5,635 (−0.9%) | August 31, 2026 |
| 8 | Fidelity Growth Company Fund | 0.64% | 598K | $7.8M | +6,300 (+1.1%) | August 31, 2026 |
| 9 | MFS New Discovery I | 0.51% | 474K | $6.2M | — | August 31, 2026 |
| 10 | T. Rowe Price New Horizons | 0.45% | 422K | $5.5M | −17,262 (−3.9%) | August 31, 2026 |
| 11 | PGIM Jennison Health Sciences Z | 0.44% | 410K | $5.3M | — | August 31, 2026 |
| 12 | T. Rowe Price Instl Small-Cap Stock | 0.43% | 399K | $5.2M | — | August 31, 2026 |
| 13 | Fidelity Blue Chip Growth | 0.38% | 352K | $4.6M | — | August 31, 2026 |
| 14 | Eventide Healthcare & Life Sciences I | 0.32% | 300K | $3.9M | +300,000 (0.0%) | June 30, 2026 |
| 15 | JPMorgan Small Cap Blend A | 0.28% | 260K | $3.4M | −5,366 (−2.0%) | August 31, 2026 |
| 16 | Fidelity Contrafund K6 | 0.27% | 257K | $3.3M | +3,732 (+1.5%) | August 31, 2026 |
| 17 | Franklin Biotechnology Discv A(acc)USD | 0.27% | 255K | $3.3M | — | August 31, 2026 |
| 18 | Principal SmallCap Growth I Instl | 0.20% | 190K | $2.5M | −35,380 (−15.7%) | August 31, 2026 |
| 19 | MFS VIT New Discovery Init | 0.19% | 175K | $2.3M | — | August 31, 2026 |
| 20 | BNY Mellon Sm/Md Cp Gr I | 0.18% | 172K | $2.2M | −1,914 (−1.1%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
Who owns KARD
Institutional investors own 78.3% of Kardigan's shares and insiders 15.58%. The largest holder is SCHF (GPE), LLC with 18.09% of the shares (16.9M), as of June 30, 2026. Among the top 20 institutions, 20 added shares and 0 reduced their stake in the latest filings. Short interest is 5.57% of the float, or 5.62 days of average trading volume.
Related: KARD analyst forecast, KARD key metrics. See the KARD stock overview for the latest quote and news.
KARD ownership FAQ
Who owns the most Kardigan stock?
The largest shareholders of Kardigan are SCHF (GPE), LLC (18.09%), FMR Inc (9.53%), Perceptive Advisors LLC (8.77%), T. Rowe Price Investment Management,Inc. (4.50%), Capital Research Global Investors (3.85%).
What percentage of Kardigan is owned by institutions?
Institutions hold 78.3% of Kardigan's shares outstanding; insiders hold 15.58%.
Which funds own Kardigan?
The largest fund holders of Kardigan are American Funds SMALLCAP World A (3.75%), T. Rowe Price Small-Cap Stock (1.44%), Fidelity Contrafund (1.34%), JPMorgan Small Cap Growth A (0.87%), iShares Russell 2000 ETF (0.79%).
What is Kardigan's short interest?
4.4M shares of Kardigan were sold short, 5.57% of the float; at the average daily volume it would take 5.62 days to cover.
How many shares of Kardigan are outstanding?
Kardigan has 93.5M shares outstanding, of which 51.8M are in the public float.